The evidence suggests that IGRA testing appears to be more specific than TST testing for identification of latent TB in individuals who have received the BCG vaccination or who are immunocompromised. The guidelines recommend IGRAs as a confirmatory test for people with a positive TST, or in individuals who are immunocompromised with a negative TST if a false-negative test is suspected.